These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33555595)

  • 1. Development of a huBLT Mouse Model to Study HCMV Latency, Reactivation, and Immune Response.
    Crawford LB; Caposio P
    Methods Mol Biol; 2021; 2244():343-363. PubMed ID: 33555595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Cytomegalovirus Induces Cellular and Humoral Virus-specific Immune Responses in Humanized BLT Mice.
    Crawford LB; Tempel R; Streblow DN; Kreklywich C; Smith P; Picker LJ; Nelson JA; Caposio P
    Sci Rep; 2017 Apr; 7(1):937. PubMed ID: 28428537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate Immune Reconstitution in Humanized Bone Marrow-Liver-Thymus (HuBLT) Mice Governs Adaptive Cellular Immune Function and Responses to HIV-1 Infection.
    Garcia-Beltran WF; Claiborne DT; Maldini CR; Phelps M; Vrbanac V; Karpel ME; Krupp KL; Power KA; Boutwell CL; Balazs AB; Tager AM; Altfeld M; Allen TM
    Front Immunol; 2021; 12():667393. PubMed ID: 34122425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signatures of T and B Cell Development, Functional Responses and PD-1 Upregulation After HCMV Latent Infections and Reactivations in Nod.Rag.Gamma Mice Humanized With Cord Blood CD34
    Theobald SJ; Khailaie S; Meyer-Hermann M; Volk V; Olbrich H; Danisch S; Gerasch L; Schneider A; Sinzger C; Schaudien D; Lienenklaus S; Riese P; Guzman CA; Figueiredo C; von Kaisenberg C; Spineli LM; Glaesener S; Meyer-Bahlburg A; Ganser A; Schmitt M; Mach M; Messerle M; Stripecke R
    Front Immunol; 2018; 9():2734. PubMed ID: 30524448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-transplantation of human fetal thymus, bone and CD34(+) cells into young adult immunodeficient NOD/SCID IL2Rγ(null) mice optimizes humanized mice that mount adaptive antibody responses.
    Chung YS; Son JK; Choi B; Joo SY; Lee YS; Park JB; Moon H; Kim TJ; Kim SH; Hong S; Chang J; Kang MS; Kim SJ
    Clin Immunol; 2015 Apr; 157(2):156-65. PubMed ID: 25725428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstitution of Human Cytomegalovirus-Specific CD4+ T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection.
    Gabanti E; Lilleri D; Ripamonti F; Bruno F; Zelini P; Furione M; Colombo AA; Alessandrino EP; Gerna G
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2192-2202. PubMed ID: 26260678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathymic injection of hematopoietic progenitor cells establishes functional T cell development in a mouse model of severe combined immunodeficiency.
    Tuckett AZ; Thornton RH; O'Reilly RJ; van den Brink MRM; Zakrzewski JL
    J Hematol Oncol; 2017 May; 10(1):109. PubMed ID: 28511686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model.
    Smith MS; Goldman DC; Bailey AS; Pfaffle DL; Kreklywich CN; Spencer DB; Othieno FA; Streblow DN; Garcia JV; Fleming WH; Nelson JA
    Cell Host Microbe; 2010 Sep; 8(3):284-91. PubMed ID: 20833379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective simultaneous quantification of human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants.
    Lilleri D; Gerna G; Fornara C; Lozza L; Maccario R; Locatelli F
    Blood; 2006 Aug; 108(4):1406-12. PubMed ID: 16614242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8-positive lymphocytes in graft-versus-host disease of humanized NOD.Cg-Prkdc(scid)Il2rg(tm1Wjl)/SzJ mice.
    Laing ST; Griffey SM; Moreno ME; Stoddart CA
    J Comp Pathol; 2015; 152(2-3):238-42. PubMed ID: 25670669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved B cell development in humanized NOD
    Jangalwe S; Shultz LD; Mathew A; Brehm MA
    Immun Inflamm Dis; 2016 Dec; 4(4):427-440. PubMed ID: 27980777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo monitoring of human cytomegalovirus-specific CD8(+) T-Cell responses using the QuantiFERON-CMV assay in allogeneic hematopoietic stem cell transplant recipients attending an Irish hospital.
    Fleming T; Dunne J; Crowley B
    J Med Virol; 2010 Mar; 82(3):433-40. PubMed ID: 20087937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
    Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
    Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition.
    Jouand N; Bressollette-Bodin C; Gérard N; Giral M; Guérif P; Rodallec A; Oger R; Parrot T; Allard M; Cesbron-Gautier A; Gervois N; Charreau B
    PLoS Pathog; 2018 Apr; 14(4):e1007041. PubMed ID: 29709038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of human cytomegalovirus-specific CD8+ T-cells in allogeneic haematopoietic stem cell transplant recipients using pentamer and interferon-γ-enzyme-linked immunospot assays.
    Liu A; Ma Y; Wu W; Chen X; Huang Y; Hu J; Liang H; Wang H; Yang R; Fan J
    J Clin Virol; 2013 Oct; 58(2):427-31. PubMed ID: 23910932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with 'humanized' antigen presentation as a new preclinical study tool.
    Lemmermann NA; Reddehase MJ
    Med Microbiol Immunol; 2016 Dec; 205(6):549-561. PubMed ID: 27539576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating Human T-Cell Therapy of Cytomegalovirus Organ Disease in HLA-Transgenic Mice.
    Thomas S; Klobuch S; Podlech J; Plachter B; Hoffmann P; Renzaho A; Theobald M; Reddehase MJ; Herr W; Lemmermann NA
    PLoS Pathog; 2015 Jul; 11(7):e1005049. PubMed ID: 26181057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse Model of Cytomegalovirus Disease and Immunotherapy in the Immunocompromised Host: Predictions for Medical Translation that Survived the "Test of Time".
    Reddehase MJ; Lemmermann NAW
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30563202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation.
    Hebart H; Daginik S; Stevanovic S; Grigoleit U; Dobler A; Baur M; Rauser G; Sinzger C; Jahn G; Loeffler J; Kanz L; Rammensee HG; Einsele H
    Blood; 2002 May; 99(10):3830-7. PubMed ID: 11986243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.
    Wu Z; Qin R; Wang L; Bosso M; Scherer M; Stamminger T; Hotter D; Mertens T; Frascaroli G
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.